Partnering with microbiologists to diagnose and prevent diseaseTM

April, 2022
Genetic engineering can help preserve endangered species Since 1978, Escherichia coli has been used in the development of synthetic “human” insulin (1). More recently, E. coli has become an essential part in the development of cancer drugs (2). Researchers at The Novo Nordisk Foundation Center for Biosustainability in Denmark have developed a method for the large-scale production of P450... Read more »